InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Fenimore Christopher R., 首席财务官. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 26 filings have been logged. Split: 0 buy · 7 sells. Total volume traded: €8.3m. Activity tracked since 20 August 2021. The latest transaction was filed on 18 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Fenimore Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报26 总计
6,283 股@ US$381.920.0028% mcap5.9% 占其流量Common StockSEC:0001697422-26-000002:0
4,599 股@ US$813.470.0044% mcap9.3% 占其流量Common StockSEC:0001697422-26-000002:1
3,027 股0Common StockSEC:0001697422-25-000004:0
491 股@ US$730.810.9% 占其流量Common StockSEC:0001883850-24-000061:0
2,591 股0Common StockSEC:0001883850-24-000050:0
228 股@ US$1,204.790.7% 占其流量Common StockSEC:0001883850-24-000045:0
344 股@ US$950.490.8% 占其流量Common StockSEC:0001968202-24-000061:0
5,000 股@ US$555.676.9% 占其流量Common StockSEC:0001968202-24-000041:0
5,000 股@ US$555.676.9% 占其流量Common StockSEC:0001883850-24-000008:0
2,448 股@ US$856.715.2% 占其流量Common StockSEC:0001883850-23-000107:0
456 股@ US$843.791.0% 占其流量Common StockSEC:0001883850-23-000103:0
2,552 股@ US$856.715.5% 占其流量Common StockSEC:0001883850-23-000101:0
474 股@ US$843.791.0% 占其流量Common StockSEC:0001968202-23-000050:0
7,000 股@ US$399.667.0% 占其流量Common StockSEC:0001968202-23-000031:0
2,192 股@ US$806.474.4% 占其流量Common StockSEC:0001883850-23-000060:0
5,000 股@ US$270.433.4% 占其流量Common StockSEC:0001883850-23-000037:0
1,926 股0Common StockSEC:0001883850-22-000131:0
247 股@ US$753.280.5% 占其流量Common StockSEC:0001883850-22-000117:0
1,844 股@ US$749.003.8% 占其流量Common StockSEC:0001883850-22-000080:0
3,346 股@ US$724.006.7% 占其流量Common StockSEC:0001883850-22-000077:0
2,450 股@ US$555.674.2% 占其流量Common StockSEC:0001708138-22-000039:0
2,000 股@ US$555.673.4% 占其流量Common StockSEC:0001883850-22-000029:0
270 股@ US$664.340.5% 占其流量Common StockSEC:0001708138-21-000106:0
1,859 股0Common StockSEC:0001883850-21-000022:0
8,719 股@ US$664.8516.8% 占其流量Common StockSEC:0001104659-21-109328:0
26 条申报中的 25 条
About Fenimore Christopher R.
Fenimore Christopher R. is Directeur Financier at Regeneron Pharmaceuticals, INC. on XNAS. He has made 24 filings in total, and in the recent filings tracked, the transactions are sales for EUR 8284645 between 2021-08-24 and 2025-12-09.
